Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05867654 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis

A Phase 4 study, sponsored by University of Louisville.

Not yet
Registry status
Phase 4
Development phase
100
Enrollment target

NCT05867654 is a Phase 4 study that has not yet begun recruiting, run by University of Louisville. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05867654, a Phase 4 study, has not yet begun recruiting, sponsored by University of Louisville.

NOT YET RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The goal of this clinical trial is compare the efficacy of oral and IV antibiotics in the treatment of orofacial osteomyelitis. The main question it aims to answer is: Are oral antibiotics as effective as IV antibiotics in the treatment of orofacial osteomyelitis. Participants, once diagnosed with osteomyelitis, will be started on oral antibiotics for their treatment. Participants will follow up with oral and maxillofacial surgery clinic accordingly and their progression and compliance will be monitored.

Interventions

  • DRUG Amoxicillin-clavulanate 875mg/125mg q12hrs
  • DRUG oral clindamycin 300mg q6hrs
  • DRUG Levofloxacin 750mg QID

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-07-31
Est. Completion 2025-12
Phase Phase 4

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT05867654

The ClinicalTrials.gov registry entry for NCT05867654 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Amoxicillin-clavulanate 875mg/125mg q12hrs is the first listed.

NCT05867654 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05867654 about?

NCT05867654 is a clinical study titled "Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis". The goal of this clinical trial is compare the efficacy of oral and IV antibiotics in the treatment of orofacial osteomyelitis. The main question it aims to answer is: Are oral antibiotics as effective as IV antibiotics in the treatment of orofacial osteomyelitis. Participants, once diagnosed with ...

What is the current status of trial NCT05867654?

This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2024-07-31. Estimated completion is 2025-12.

What interventions are being tested in trial NCT05867654?

The interventions under investigation include: Amoxicillin-clavulanate 875mg/125mg q12hrs (DRUG), oral clindamycin 300mg q6hrs (DRUG), Levofloxacin 750mg QID (DRUG).

Who is sponsoring clinical trial NCT05867654?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.